High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling

Zhang,Dayong; Lu,Huifei; Chen,Zhongxing; Wang,Yayan; Lin,Jiuzhou; Xu,Shan; Zhang,Chong; Wang,Baoming; Yuan,Zhanggen; Feng,Xiao; Jiang,Xuefan; Pan,Jianping

doi:10.3892/mmr.2017.6832

High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling

Authors:
- Dayong Zhang
- Huifei Lu
- Zhongxing Chen
- Yayan Wang
- Jiuzhou Lin
- Shan Xu
- Chong Zhang
- Baoming Wang
- Zhanggen Yuan
- Xiao Feng
- Xuefan Jiang
- Jianping Pan
View Affiliations

Affiliations: Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Zhejiang 310015, P.R. China, Clinical Laboratory, The Second People's Hospital of Hangzhou, Hangzhou, Zhejiang 310015, P.R. China, Department of Otorhinolaryngology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China
Published online on: June 21, 2017 https://doi.org/10.3892/mmr.2017.6832
Pages: 1685-1690
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It has previously been demonstrated that glucose is important in the process of stem cell aging. However, the mechanisms of cell senescence induced by high glucose (HG) remain to be elucidated. The preliminary study indicated that D‑galactose induced mesenchymal stem cell (MSCs) aging. The present study demonstrated, following treatment with 11.0 or 22.0 mM HG for 14 days, that HG significantly promoted MSCs aging and the expression levels of phosphorylated (p-)phosphatidylinositol 3-kinase/protein kinase B (Akt) and p‑mammalian target of rapamycin signaling (mTOR) in the HG groups were increased compared with the control group. However, following Akt inhibition with 1.0 or 10.0 nM MK‑2206, which is an Akt‑specific small molecule inhibitor, the senescence‑cell value in the HG group was significantly decreased compared with the control group. These results indicated that HG induced MSCs senescence and this effect was primarily mediated via the Akt/mTOR signaling pathway.

View Figures

View References

1	Schultz MB and Sinclair DA: When stem cells grow old: Phenotypes and mechanisms of stem cell aging. Development. 143:3–14. 2016. View Article : Google Scholar : PubMed/NCBI
2	Brunauer R and Kennedy BK: Medicine. Progeria accelerates adult stem cell aging. Science. 348:1093–1094. 2015. View Article : Google Scholar : PubMed/NCBI
3	Miura Y: Guest editorial: Human mesenchymal stromal/stem cell (MSC). Int J Hematol. 103:119–121. 2016. View Article : Google Scholar : PubMed/NCBI
4	Asumda FZ: Age-associated changes in the ecological niche: Implications for mesenchymal stem cell aging. Stem Cell Res Ther. 4:472013. View Article : Google Scholar : PubMed/NCBI
5	de Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, Arias J and Arnalich-Montiel F: Immunosuppressive properties of mesenchymal stem cells: Advances and applications. Curr Mol Med. 12:574–591. 2012. View Article : Google Scholar : PubMed/NCBI
6	Ankrum J and Karp JM: Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med. 16:203–209. 2010. View Article : Google Scholar : PubMed/NCBI
7	Alt EU, Senst C, Murthy SN, Slakey DP, Dupin CL, Chaffin AE, Kadowitz PJ and Izadpanah R: Aging alters tissue resident mesenchymal stem cell properties. Stem Cell Res. 8:215–225. 2012. View Article : Google Scholar : PubMed/NCBI
8	Ting CH, Ho PJ and Yen BL: Age-related decreases of serum-response factor levels in human mesenchymal stem cells are involved in skeletal muscle differentiation and engraftment capacity. Stem Cells Dev. 23:1206–1216. 2014. View Article : Google Scholar : PubMed/NCBI
9	Khan M, Mohsin S, Khan SN and Riazuddin S: Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J Cell Mol Med. 15:1515–1527. 2011. View Article : Google Scholar : PubMed/NCBI
10	Zhang DY, Wang HJ and Tan YZ: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS One. 6:e213972011. View Article : Google Scholar : PubMed/NCBI
11	Zhang E, Guo Q, Gao H, Xu R, Teng S and Wu Y: Metformin and resveratrol inhibited high glucose-induced metabolic memory of endothelial senescence through SIRT1/p300/p53/p21 pathway. PLoS One. 10:e01438142015. View Article : Google Scholar : PubMed/NCBI
12	del Nogal M, Troyano N, Calleros L, Griera M, Rodriguez-Puyol M, Rodriguez-Puyol D and Ruiz-Torres MP: Hyperosmolarity induced by high glucose promotes senescence in human glomerular mesangial cells. Int J Biochem Cell Biol. 54:98–110. 2014. View Article : Google Scholar : PubMed/NCBI
13	Güemes M, Rahman SA and Hussain K: What is a normal blood glucose? Arch Dis Child. 101:569–574. 2016. View Article : Google Scholar : PubMed/NCBI
14	Cheng NC, Hsieh TY, Lai HS and Young TH: High glucose-induced reactive oxygen species generation promotes stemness in human adipose-derived stem cells. Cytotherapy. 18:371–383. 2016. View Article : Google Scholar : PubMed/NCBI
15	Ferraro F, Lymperi S, Méndez-Ferrer S, Saez B, Spencer JA, Yeap BY, Masselli E, Graiani G, Prezioso L, Rizzini EL, et al: Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med. 3:104ra1012011. View Article : Google Scholar : PubMed/NCBI
16	Kočí Z, Turnovcová K, Dubský M, Baranovičová L, Holáň V, Chudíčková M, Syková E and Kubinová S: Characterization of human adipose tissue-derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia. Cell Biochem Funct. 32:597–604. 2014. View Article : Google Scholar : PubMed/NCBI
17	Stolzing A, Coleman N and Scutt A: Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res. 9:31–35. 2006. View Article : Google Scholar : PubMed/NCBI
18	Parsch D, Fellenberg J, Brummendorf TH, Eschlbeck AM and Richter W: Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med (Berl). 82:49–55. 2004. View Article : Google Scholar : PubMed/NCBI
19	Estrada JC, Torres Y, Benguría A, Dopazo A, Roche E, Carrera-Quintanar L, Pérez RA, Enríquez JA, Torres R, Ramírez JC, et al: Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis. 4:e6912013. View Article : Google Scholar : PubMed/NCBI
20	Liu S, Liu S, Wang X, Zhou J, Cao Y, Wang F and Duan E: The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro. Aging Cell. 10:661–674. 2011. View Article : Google Scholar : PubMed/NCBI
21	Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell JB and Gutkind JS: mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell. 11:401–414. 2012. View Article : Google Scholar : PubMed/NCBI
22	Zhang D, Yan B, Yu S, Zhang C, Wang B, Wang Y, Wang J, Yuan Z, Zhang L and Pan J: Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling. Oxid Med Cell Longev. 2015:8672932015. View Article : Google Scholar : PubMed/NCBI
23	Wang XM, Yao M, Liu SX, Hao J, Liu QJ and Gao F: Interplay between the notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis. Am J Physiol Renal Physiol. 306:F205–F213. 2014. View Article : Google Scholar : PubMed/NCBI
24	Montes DK, Brenet M, Muñoz VC, Burgos PV, Villanueva CI, Figueroa CD and González CB: Vasopressin activates Akt/mTOR pathway in smooth muscle cells cultured in high glucose concentration. Biochem Biophys Res Commun. 441:923–928. 2013. View Article : Google Scholar : PubMed/NCBI
25	Guan G, Han H, Yang Y, Jin Y, Wang X and Liu X: Neferine prevented hyperglycemia-induced endothelial cell apoptosis through suppressing ROS/Akt/NF-κB signal. Endocrine. 47:764–771. 2014. View Article : Google Scholar : PubMed/NCBI
26	Wakao S, Kuroda Y, Ogura F, Shigemoto T and Dezawa M: Regenerative effects of mesenchymal stem cells: Contribution of muse cells, a novel pluripotent stem cell type that resides in mesenchymal cells. Cells. 1:1045–1060. 2012. View Article : Google Scholar : PubMed/NCBI
27	Tomé M, Sepúlveda JC, Delgado M, Andrades JA, Campisi J, González MA and Bernad A: miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity. Stem Cells. 32:2229–2244. 2014. View Article : Google Scholar : PubMed/NCBI
28	Raggi C and Berardi AC: Mesenchymal stem cells, aging and regenerative medicine. Muscles Ligaments Tendons J. 2:239–242. 2012.PubMed/NCBI
29	Rachmiel M, Cohen M, Heymen E, Lezinger M, Inbar D, Gilat S, Bistritzer T, Leshem G, Kan-Dror E, Lahat E and Ekstein D: Hyperglycemia is associated with simultaneous alterations in electrical brain activity in youths with type 1 diabetes mellitus. Clin Neurophysiol. 127:1188–1195. 2016. View Article : Google Scholar : PubMed/NCBI
30	Galindo RJ and Wallia A: Hyperglycemia and diabetes mellitus following organ transplantation. Curr Diab Rep. 16:142016. View Article : Google Scholar : PubMed/NCBI
31	Kojima H, Kim J and Chan L: Emerging roles of hematopoietic cells in the pathobiology of diabetic complications. Trends Endocrinol Metab. 25:178–187. 2014. View Article : Google Scholar : PubMed/NCBI
32	Chang TC, Hsu MF and Wu KK: High glucose induces bone marrow-derived mesenchymal stem cell senescence by upregulating autophagy. PLoS One. 10:e01265372015. View Article : Google Scholar : PubMed/NCBI
33	Zhang DY, Pan Y, Zhang C, Yan BX, Yu SS, Wu DL, Shi MM, Shi K, Cai XX, Zhou SS, et al: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production. Mol Cell Biochem. 374:13–20. 2013. View Article : Google Scholar : PubMed/NCBI
34	Liu L, Hu X, Cai GY, Lv Y, Zhuo L, Gao JJ, Cui SY, Feng Z, Fu B and Chen XM: High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Nephrol Dial Transplant. 27:90–100. 2012. View Article : Google Scholar : PubMed/NCBI
35	Montani MS Gilardini, Granato M, Cuomo L, Valia S, Di Renzo L, D'Orazi G, Faggioni A and Cirone M: High glucose and hyperglycemic sera from type 2 diabetic patients impair DC differentiation by inducing ROS and activating Wnt/β-catenin and p38 MAPK. Biochim Biophys Acta. 1862:805–813. 2016. View Article : Google Scholar : PubMed/NCBI
36	Mehrfarjam Z, Esmaeili F, Shabani L and Ebrahimie E: Induction of pancreatic β cell gene expression in mesenchymal stem cells. Cell Biol Int. 40:486–500. 2016. View Article : Google Scholar : PubMed/NCBI
37	Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H and Wang KX: Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl). 120:771–776. 2007.PubMed/NCBI
38	Hashemian SJ, Kouhnavard M and Nasli-Esfahani E: Mesenchymal stem cells: Rising concerns over their application in treatment of type one diabetes mellitus. J Diabetes Res. 2015:6751032015. View Article : Google Scholar : PubMed/NCBI
39	Rekittke NE, Ang M, Rawat D, Khatri R and Linn T: Regenerative therapy of type 1 diabetes mellitus: From pancreatic islet transplantation to mesenchymal stem cells. Stem Cells Int. 2016:37646812016. View Article : Google Scholar : PubMed/NCBI
40	Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, Agostini C and Avogaro A: Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia. 49:3075–3084. 2006. View Article : Google Scholar : PubMed/NCBI
41	Shin L and Peterson DA: Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. Stem Cells Transl Med. 1:125–135. 2012. View Article : Google Scholar : PubMed/NCBI